Literature DB >> 21300207

PARP inhibitor treatment in ovarian and breast cancer.

Marcie K Weil1, Alice P Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21300207      PMCID： PMC3063418          DOI： 10.1016/j.currproblcancer.2010.12.002

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  109 in total

1.  DNA strand breaks and ADP-ribosyl transferase activation during cell differentiation.

Authors:  F Farzaneh; R Zalin; D Brill; S Shall
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

2.  PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase.

Authors:  J C Amé; V Rolli; V Schreiber; C Niedergang; F Apiou; P Decker; S Muller; T Höger; J Ménissier-de Murcia; G de Murcia
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

3.  Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.

Authors:  P A Futreal; P Söderkvist; J R Marks; J D Iglehart; C Cochran; J C Barrett; R W Wiseman
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

4.  Frequency of BRCA1 dysfunction in ovarian cancer.

Authors:  John P Geisler; Melanie A Hatterman-Zogg; Jennifer A Rathe; Richard E Buller
Journal:  J Natl Cancer Inst       Date:  2002-01-02       Impact factor: 13.506

5.  Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage.

Authors:  S Boulton; S Kyle; B W Durkacz
Journal:  Carcinogenesis       Date:  1999-02       Impact factor: 4.944

6.  Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry.

Authors:  W Blum; J W Faigle; U Pfaar; A Sallmann
Journal:  J Chromatogr B Biomed Appl       Date:  1996-10-25

Review 7.  In vivo reversion to normal of inherited mutations in humans.

Authors:  R Hirschhorn
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

8.  Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Authors:  Niklas Schultz; Elena Lopez; Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

9.  PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites.

Authors:  Jean-François Haince; Darin McDonald; Amélie Rodrigue; Ugo Déry; Jean-Yves Masson; Michael J Hendzel; Guy G Poirier
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

10.  Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development.

Authors:  Y Jeffrey Chiang; Susan J Hsiao; Dena Yver; Samuel W Cushman; Lino Tessarollo; Susan Smith; Richard J Hodes
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240
View more
  56 in total

Review 1.  Pathway perturbations in signaling networks: Linking genotype to phenotype.

Authors:  Yongsheng Li; Daniel J McGrail; Natasha Latysheva; Song Yi; M Madan Babu; Nidhi Sahni
Journal:  Semin Cell Dev Biol       Date:  2018-05-10       Impact factor: 7.727

2.  Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins.

Authors:  Alejandro Speck-Planche; M Natália D S Cordeiro
Journal:  Mol Divers       Date:  2017-02-13       Impact factor: 2.943

3.  Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21.

Authors:  Dae-Seok Kim; Cristel V Camacho; Anusha Nagari; Venkat S Malladi; Sridevi Challa; W Lee Kraus
Journal:  Mol Cell       Date:  2019-07-24       Impact factor: 17.970

4.  Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population.

Authors:  Kai Li; Wusheng Li
Journal:  Mol Cell Biochem       Date:  2012-09-16       Impact factor: 3.396

5.  Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.

Authors:  Nana Aburjania; Alexander M Truskinovsky; Michael J Overman; Emil Lou
Journal:  J Gastrointest Cancer       Date:  2014-03

6.  The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells.

Authors:  Hong Jue Lee; Petra Burger; Marianne Vogel; Klaus Friese; Ansgar Brüning
Journal:  Invest New Drugs       Date:  2012-07-22       Impact factor: 3.850

7.  PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.

Authors:  Haiying Cheng; Zhenfeng Zhang; Alain Borczuk; Charles A Powell; Adayabalam S Balajee; Howard B Lieberman; Balazs Halmos
Journal:  Carcinogenesis       Date:  2012-12-28       Impact factor: 4.944

8.  Krüppel-like factor 8 emerges as an important regulator of cancer.

Authors:  Satadru K Lahiri; Jihe Zhao
Journal:  Am J Transl Res       Date:  2012-07-27       Impact factor: 4.060

9.  Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body production.

Authors:  Ahmed F Salem; Anthony Howell; Marina Sartini; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-10-09       Impact factor: 4.534

10.  Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer.

Authors:  Shelly Gunn; Xavier Reveles; Korrie Weldon; Andres Barrera; Mariam Ishaque; Dale Taylor; Chris McCaskill; Jaeweon Kim; Rashmi Shah; Mansoor Mohammed; Todd Barry; Brianne Kaiser; Amita Patnaik; Anthony Tolcher
Journal:  J Ovarian Res       Date:  2013-01-04       Impact factor: 4.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.